[Form 4] KEWAUNEE SCIENTIFIC CORP /DE/ Insider Trading Activity

Rhea-AI Filing Summary

Elizabeth D. Phillips, listed as a director and Vice President - Human Resources of Kewaunee Scientific Corp (KEQU), reported insider sales on 10/02/2025. The filing shows a sale of 6,877 shares at a weighted-average price of $43.20 (price range $43.05–$43.95), followed by an additional sale of 3 shares at $44.20. After the transactions the reporting person beneficially owned 8,251 shares and then 8,248 shares (direct ownership). The Form 4 was signed by an attorney-in-fact, Donald T. Gardner III. The filer also states availability of per-price purchase breakdown upon request.

Positive

• Timely, detailed disclosure of insider sales with weighted-average price and price range provided
• Reporting includes direct ownership amounts after each transaction, aiding transparency

Negative

• Insider sold 6,877 shares at a weighted-average price of $43.20, representing a reduction in holdings
• Additional small sale of 3 shares at $44.20 further reduced direct holdings

Insights

Securities Analyst

TL;DR: Insider sales reported; sizes appear modest and the filing is procedural and compliant.

The Form 4 discloses routine dispositions by an officer/director rather than grants or derivative activity. The weighted-average price and disclosed price range provide transparency on execution. The residual direct holdings of ~8.2k shares remain after the sales. Without comparative position size or company outstanding shares, the market-impact significance is unclear; the filing should be interpreted as a compliance disclosure of insider selling rather than evidence of company-level material change.

Corporate Governance Expert

TL;DR: Filing meets Section 16 requirements; signature by attorney-in-fact is properly noted.

The document identifies the reporting person’s roles and provides transaction details including dates, quantities, prices, and a clear explanation that the reported price is a weighted average with a stated price range. The presence of an attorney-in-fact signature is acceptable when properly executed and dated. This Form 4 conveys transparent insider activity; governance reviewers would treat it as routine disclosure requiring no immediate escalated action absent additional context.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Phillips Elizabeth D

(Last) (First) (Middle)

2700 WEST FRONT STREET

(Street)

STATESVILLE NC 28677

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP - Human Resources

3. Date of Earliest Transaction (Month/Day/Year)
10/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/02/2025		S		6,877	D	$43.2(1)	8,251	D
Common Stock	10/02/2025		S		3	D	$44.2	8,248	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reflects the weighted average purchase price of the transactions reported. The price range of such transactions was $43.05 to $43.95. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares purchased at each separate price.

Remarks:

	/s/ Donald T. Gardner III, Attorney-in-fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for KEQU?

The Form 4 was filed on behalf of Elizabeth D. Phillips, Director and Vice President - Human Resources.

What insider transactions were reported for KEQU on 10/02/2025?

Sales of 6,877 shares at a weighted-average price of $43.20 (range $43.05–$43.95) and 3 shares at $44.20.

How many shares did the reporting person own after the transactions?

The filing shows direct beneficial ownership of 8,251 shares after the first sale and 8,248 shares after the second sale.

Was the Form 4 properly signed?

Yes. The Form 4 was signed by an attorney-in-fact, Donald T. Gardner III, dated 10/02/2025.

Does the filing provide price detail for each share lot?

The filing states the reported price is a weighted average and that a per-price breakdown is available upon request.